BARON-COHEN, S. , SCAHILL, V.L. , IZAGUIRRE, J. , HORNSEY, H. & ROBERTSON, M .M. (1999) ‘The Prevalence of Gilles de la Tourette Syndrome in Children and Adolescents with Autism: A Large Scale Study’ , Psychological Medicine29: 1151–1159 .
2.
BERKSON, G. (1964) ‘Stereotyped Movements of Mental Defectives.V:Ward Behaviour and Its Relation to an Experimental Task’ , American Journal of Mental Deficiency69: 253–264 .
3.
BERKSON, G. & DAVENPORT, R .K. (1962) ‘Stereotyped Movements of Mental Defectives. I: Initial Study’ , American Journal of Mental Deficiency66: 849–852 .
4.
BHARUCHA, K .J. & SETHI, K .D. (1995) ‘Tardive Tourettism after Exposure to Neuroleptic Therapy’ , Movement Disorders10 (6): 791–773 .
5.
CAMPBELL, M. (1999) ‘Risperidone Induced Tardive Dyskinesia in First Episode Psychotic Patients (Letter to Editor)’ , Journal of Clinical Psychopharmacology19 (3): 276–227 .
FISHMAN, S. & STEELE, M. (1996) ‘Use of Risperidone in Pervasive Developmental Disorders: A Case Series’ , Journal of Child and Adolescent Psychopharmacology6 (3): 177–190 .
8.
FREEMAN, B.J. , RITVO, E .R. , SCHROTH, P.C. , TONICK, I. , GUTHRIE, D. & WAKE, L. (1981) ‘Behavioural Characteristics of High and Low IQ Autistic Children’ , American Journal of Psychiatry138 (1): 25–29 .
9.
KRAIJER, D. (1999) ‘Autism and Autistic-Like Conditions in Mental Retardation’ , Journal of Intellectual Disability Research43 (4): 341–333 .
10.
LYCOURAS, L. , YANNAKIS, R. , HATZIMANOLIS, J. & CHRISTODOULOU, G.N. (1999) ‘Two Cases of Risperidone Induced Tardive Dyskinesia and a Review of the Literature’ , European Psychiatry14 (4): 245–227 .
11.
MCDOUGLE, C.J. , HOLMES, J.P. , BRONSON, M .R. , ANDERSON, G.M. , VOLKMAR, F.R. , PRICE, L .H. & COHEN, D.J. (1997) ‘Risperidone Treatment of Children and Adolescents with Pervasive Developmental Disorders: A Prospective Open Label Study’ , Journal of the American Academy of Child and Adolescent Psychiatry36 (5): 685–693 .
12.
MALONE, R .P. , MAISLIN, G. , CHOUDHURY, M .S. , GIFFORD, C. & DELANEY, M .A. (2002) ‘Risperidone Treatment in Children and Adolescents with Autism: Short and Long Term Safety and Effectiveness’ , Journal of the American Academy of Child and Adolescent Psychiatry41 (2): 140–117 .
13.
MASI, G. , COSENZA, A. , MUCCI, M. & DE VITO, G. (2001) ‘Risperidone Monotherapy in Preschool Children with Pervasive Developmental Disorders’ , Journal of Child Neurology16 (6): 395–400 .
14.
MEISELAS, K .D. , SPENCER, E .K. , OBERFIELD, R., PESELOW, E. , ANGRIST, B. & CAMPBELL, M. (1989) ‘Differentiation of Stereotypies from Neuroleptic-Related Dyskinesias in Autistic Children’ , Journal of Clinical Psychopharmacology9 (3): 207–229 .
15.
MUELLER, J. & AMINOFF, M .J. (1982) ‘Tourette-Like Syndrome after Long-Term Neuroleptic Drug Treatment’ , British Journal of Psychiatry141: 191–113 .
16.
MUNETZ, M .R. & BENJAMIN, S. (1988) ‘How To Examine Patients Using the Abnormal Involuntary Movement Scale’ , Hospital and Community Psychiatry39 (11): 1172–1177 .
17.
NICE (2002) ‘Guidance on the Use of Newer (Atypical) Antipsychotic Drugs for the Treatment of Schizophrenia’ .Technology Appraisal Guidance43. http://www.nice.org.uk/page.aspx?o=32934, June 2002.
18.
PERRY, R. , PATAKI, C. , MUNOZ-SILVA, D.M. , ARMENTEROS, J. & SILVA, R .R. (1997) ‘Risperidone in Children and Adolescents with Pervasive Developmental Disorder: Pilot Trial and Follow-Up’ , Journal of Child and Adolescent Psychopharmacology7 (3): 167–179 .
19.
PRINGSHEIM, T. , DAVENPORT, W.J. & LANG, A. (2003) ‘Tics’ , Current Opinion in Neurology16 (4): 523–557 .
20.
RINGMAN, J.M. & JANKOVIC, J. (2000) ‘Occurrence of Tics in Asperger's Syndrome and Autistic Disorder’ , Journal of Child Neurology15 (6): 394–400 .
21.
ROWAN, A .B. & MALONE, R .P. (1997) ‘Tics with Risperidone Withdrawal’ , Journal of the American Academy of Child & Adolescent Psychiatry36 (2): 162–113 .
22.
SCAHILL, L. ET AL. (2002) ‘Risperidone in Children with Autism and Serious Behavioural Problems’ , New England Journal of Medicine347 (5): 314–321 .
23.
SCAHILL, L. , LECKMAN, J.F. , SCHULTZ, R .T. , KATSOVICH, L. & PATERSON, B.S. (2003) ‘A Placebo-Controlled Trial of Risperidone in Tourette Syndrome’ , Neurology60 (7): 1130–1135 .
24.
SHAY, J. , SANCHEZ, L .E. , CUEVA, J.E. , ARMENTEROS, J.L. , OVERALL, J.E. & CAMPBELL, M. (1993) ‘Neuroleptic Related Dyskinesia and Stereotypies in Autistic Children:Videotaped Ratings’ , Psychopharmacology Bulletin29 (3): 359–363 .
SPINA, E. , AVENOSO, A. , FACCIOLA, G. , SCORDO, M .G. , ANCIONE, M. & MADIA, A. (2001) ‘Plasma Concentrations of Risperidone and 9-Hydroxyrisperidone during Combined Treatment with Paroxetine’ , Therapeutic Drug Monitoring23: 223–227 .
27.
SPINA, E. , AVENOSO, A. , SCORDO, M .G. , ANCIONE, M. , MADIA, A. , GATTI, G. & PERUCCA, E. (2002) ‘Inhibition of Risperidone Metabolism by Fluoxetine in Patients with Schizophrenia: A Clinically Relevant Pharmacokinetic Drug Interaction’ , Journal of Clinical Psychopharmacology22 (4): 419–423 .
28.
STAHL, S .M. (1980) ‘Tardive Tourette Syndrome in an Autistic Patient after Long-Term Neuroleptic Administration’ , American Journal of Psychiatry137 (10): 1267–1269 .
29.
STEELE, M. & COUTURIER, J. (1999) ‘A Possible Tetracycline–Risperidone–Sertraline Interaction in an Adolescent’ , Canadian Journal of Clinical Pharmacology6 (1): 15–17 .
30.
ZUDDAS, A. , MARTINO, A .D. , MUGLIA, P. & CIANCHETTI, C. (2000) ‘Long Term Risperidone for Pervasive Developmental Disorders: Efficacy,Tolerability and Discontinuation’ , Journal of Child and Adolescent Psychopharmacology10 (2): 79–90 .